Browsing Search Results

Matched Description: , galactose-1-phosphate uridylyltransferase and UDP-glucose 4-epimerase. Beta-D-galactose can be uptaken … degradation involving a lactose permease to uptake lactose from the environment and a beta-galactosidase … lactose interacts with water through a beta-galactosidase resulting in a beta-D-glucose and beta-D … -D-glucose 1-phosphate) interacts with UTP and a hydrogen ion in order to produce a uridine … output a glucose-1-phosphate and a uridine diphosphate galactose. The glucose -1-phosphate is

Matched Description: metabolism (IEM) and autosomal recessive disorder caused by a defective liver glycogen phosphorylase … 1,4-alpha-glucan-branching enzyme and glycogen debranching enzyme. The disorder may show as enlarged

Matched Description: with Adenylate Cyclase Type 2, Adeonsine Triphosphate, as well as GTP and magnesium to produce cAMP … and Pyrophosphate. cAMP then activates PKA (protein kinase A) which leads to changes in the concentration of water in urine.

Matched Description: , and others. BH4 is a cofactor involved in many things and associated with neurotransmitter

Matched Description: , occuring in meat, fish and dairy products. Due to its methylation, it cannot be a substrate for acyl-CoA … dehydrogenase and cannot enter the mitochondrial beta oxidation pathway. Phytanic acid is instead

Matched Description: inside the cytoplasm, it is protonated and this protonated form enters and blocks the pore of the

Matched Description: . Once inside the cytoplasm, it is protonated and this protonated form enters and blocks the pore of

Matched Description: with Adenylate Cyclase Type 2, Adeonsine Triphosphate, as well as GTP and magnesium to produce cAMP … and Pyrophosphate. cAMP then activates PKA (protein kinase A) which leads to changes in the concentration of water in urine.

Matched Description: administered intravenously, and can act to decrease platelet aggregation for up to two days after … conformational change also prevents the binding of von Willebrand factor to the platelets, which also prevents aggregation and adhesion.

Matched Description: . It functions primarily as a μ-opioid receptor antagonist and is used primarily in combination with … , for the treatment of bipolar disorder and for the treatment of schizophrenia in adults. It is … remains to be determined. Samidorphan functions primarily as a μ-opioid receptor antagonist and as … - and δ-opioid receptors in vitro. Samidorphan inhibits the exchange of GTP for GDP which is … calcium to enter the neuron and depolarize. The inhibition of mu-opioid receptors prevents